Araujo A - Search Results

1

Exosomes isolation and characterization in serum is feasible in non-small cell lung cancer patients: critical analysis of evidence and potential role in clinical practice.

Taverna S, Giallombardo M, Gil-Bazo I, Carreca AP, Castiglia M, Chacártegui J, Araujo A, Alessandro R, Pauwels P, Peeters M, Rolfo C. Taverna S, et al. Among authors: araujo a. Oncotarget. 2016 May 10;7(19):28748-60. doi: 10.18632/oncotarget.7638. Oncotarget. 2016. PMID: 26919248 Free PMC article. Review.

2

Combined Ang-2 and VEGF serum levels: holding hands as a new integral biomarker in non-small-cell lung cancers.

Coelho AL, Araújo AM, Gomes MP, Catarino RJ, Andrade EB, Lopes AM, Medeiros RM. Coelho AL, et al. Future Oncol. 2015;11(24):3233-42. doi: 10.2217/fon.15.207. Epub 2015 Nov 12. Future Oncol. 2015. PMID: 26562248

3

Angiogenesis in NSCLC: is vessel co-option the trunk that sustains the branches?

Coelho AL, Gomes MP, Catarino RJ, Rolfo C, Lopes AM, Medeiros RM, Araújo AM. Coelho AL, et al. Oncotarget. 2017 Jun 13;8(24):39795-39804. doi: 10.18632/oncotarget.7794. Oncotarget. 2017. PMID: 26950275 Free PMC article. Review.

4

Exosomes genetic cargo in lung cancer: a truly Pandora's box.

Reclusa P, Sirera R, Araujo A, Giallombardo M, Valentino A, Sorber L, Bazo IG, Pauwels P, Rolfo C. Reclusa P, et al. Among authors: araujo a. Transl Lung Cancer Res. 2016 Oct;5(5):483-491. doi: 10.21037/tlcr.2016.10.06. Transl Lung Cancer Res. 2016. PMID: 27826529 Free PMC article. Review.

5

Immunotherapy in NSCLC: A Promising and Revolutionary Weapon.

Rolfo C, Caglevic C, Santarpia M, Araujo A, Giovannetti E, Gallardo CD, Pauwels P, Mahave M. Rolfo C, et al. Among authors: araujo a. Adv Exp Med Biol. 2017;995:97-125. doi: 10.1007/978-3-319-53156-4_5. Adv Exp Med Biol. 2017. PMID: 28321814 Review.

6

FGFR a promising druggable target in cancer: Molecular biology and new drugs.

Porta R, Borea R, Coelho A, Khan S, Araújo A, Reclusa P, Franchina T, Van Der Steen N, Van Dam P, Ferri J, Sirera R, Naing A, Hong D, Rolfo C. Porta R, et al. Among authors: araujo a. Crit Rev Oncol Hematol. 2017 May;113:256-267. doi: 10.1016/j.critrevonc.2017.02.018. Epub 2017 Mar 23. Crit Rev Oncol Hematol. 2017. PMID: 28427515 Review.

7

CSF-1 and Ang-2 serum levels - prognostic and diagnostic partners in non-small cell lung cancer.

Coelho AL, Gomes MP, Catarino RJ, Rolfo C, Medeiros RM, Araújo AM. Coelho AL, et al. ESMO Open. 2018 Jul 25;3(5):e000349. doi: 10.1136/esmoopen-2018-000349. eCollection 2018. ESMO Open. 2018. PMID: 30094067 Free PMC article.

8

Real-World Experience in Treatment of Patients with Non-Small-Cell Lung Cancer with BRAF or cMET Exon 14 Skipping Mutations.

Janzic U, Shalata W, Szymczak K, Dziadziuszko R, Jakopovic M, Mountzios G, Płużański A, Araujo A, Charpidou A, Agbarya A. Janzic U, et al. Among authors: araujo a. Int J Mol Sci. 2023 Aug 16;24(16):12840. doi: 10.3390/ijms241612840. Int J Mol Sci. 2023. PMID: 37629023 Free PMC article.

9

Vitiligo-like Lesions as a Predictor of Response to Immunotherapy in Non-Small Cell Lung Cancer: Comprehensive Review and Case Series from a University Center.

Coelho JQ, Romão R, Sousa MJ, Azevedo SX, Fidalgo P, Araújo A. Coelho JQ, et al. Among authors: araujo a. Curr Oncol. 2024 Feb 19;31(2):1113-1128. doi: 10.3390/curroncol31020083. Curr Oncol. 2024. PMID: 38392077 Free PMC article.

10

Prognostic value of microRNA-203a expression in breast cancer.

Gomes BC, Martins M, Lopes P, Morujão I, Oliveira M, Araújo A, Rueff J, Rodrigues AS. Gomes BC, et al. Among authors: araujo a. Oncol Rep. 2016 Sep;36(3):1748-56. doi: 10.3892/or.2016.4913. Epub 2016 Jul 5. Oncol Rep. 2016. PMID: 27431784

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,984 results

Search Page